Our previous studies indicated that cystatin C, a biomarker of early renal impairs, was higher in several OSA patients without complications [4], and continuous positive airway pressure (CPAP) treatment can normalize cystatin C levels in those patients [5]. The gene discussed is CST3; the disease is obstructive sleep apnea syndrome.